TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $21,348 | +601.8% | 1,200 | +500.0% | 0.01% | +600.0% |
| Q1 2024 | $3,042 | -85.2% | 200 | -83.3% | 0.00% | -87.5% |
| Q4 2023 | $20,496 | +92.3% | 1,200 | -5.9% | 0.01% | +60.0% |
| Q3 2023 | $10,659 | -66.3% | 1,275 | 0.0% | 0.01% | -64.3% |
| Q2 2023 | $31,671 | +65.2% | 1,275 | 0.0% | 0.01% | +55.6% |
| Q1 2023 | $19,176 | +27.1% | 1,275 | 0.0% | 0.01% | +12.5% |
| Q4 2022 | $15,083 | +88.5% | 1,275 | 0.0% | 0.01% | +100.0% |
| Q3 2022 | $8,000 | +60.0% | 1,275 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $5,000 | +66.7% | 1,275 | +363.6% | 0.00% | +100.0% |
| Q1 2022 | $3,000 | -87.5% | 275 | -78.4% | 0.00% | -90.0% |
| Q4 2021 | $24,000 | -65.7% | 1,275 | -39.3% | 0.01% | -68.8% |
| Q3 2021 | $70,000 | – | 2,100 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,280,000 | $40,561,200 | 9.27% |
| Soleus Capital Management, L.P. | 3,645,562 | $64,854,548 | 5.72% |
| Exome Asset Management LLC | 251,600 | $4,475,964 | 3.90% |
| M28 Capital Management LP | 161,600 | $2,874,864 | 3.73% |
| Ghost Tree Capital, LLC | 500,000 | $8,895,000 | 2.78% |
| 683 Capital Management, LLC | 1,400,000 | $24,906,000 | 1.88% |
| Sofinnova Investments, Inc. | 1,861,277 | $33,112,118 | 1.72% |
| Deep Track Capital, LP | 2,870,131 | $51,059,630 | 1.52% |
| Parkwood LLC | 147,680 | $9,847 | 1.22% |
| Spotlight Asset Group, Inc. | 82,100 | $1,460,559 | 1.02% |